Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Trial · NCT01107743
Trial comparisons28
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 20 of 28
Download this page as JSON| Comparison | Source |
|---|---|
| Without Complications vs With Complications: Risk Factors for the Proportion of Responders for Hypercholesterolemia or Familial Hypercholesterolemia -Complications. | Trial comparisons |
| Without Concomitant Drugs vs With Concomitant Drugs: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Concomitant Drugs. | Trial comparisons |
| Without Concomitant Drugs vs With Concomitant Drugs: Risk Factors for the Proportion of Responders for Angina Pectoris -Concomitant Drugs. | Trial comparisons |
| <65 Years vs >=65 Years: Risk Factors for the Proportion of Responders for Hypercholesterolemia or Familial Hypercholesterolemia -Age. | Trial comparisons |
| Without Complications vs With Complications: Risk Factors for the Proportion of Responders for Angina Pectoris -Complications. | Trial comparisons |
| <65 Years vs >=65 Years: Risk Factors for the Proportion of Responders for Angina Pectoris -Age. | Trial comparisons |
| Without Renal Dysfunction vs With Renal Dysfunction: Risk Factors for the Proportion of Responders for Angina Pectoris -Renal Dysfunction. | Trial comparisons |
| Male vs Female: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Gender. | Trial comparisons |
| Without Hepatic Dysfunction vs With Hepatic Dysfunction: Risk Factors for the Proportion of Responders for Hypercholesterolemia or Familial Hypercholesterolemia -Hepatic Dysfunction. | Trial comparisons |
| Without Hypertension vs With Hypertension: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Hypertension. | Trial comparisons |
| Without Hepatic Dysfunction vs With Hepatic Dysfunction: Risk Factors for the Proportion of Responders for Hypertension -Hepatic Dysfunction. | Trial comparisons |
Without Hypercholesterolemia vs With Hypercholesterolemia: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Hypercholesterolemia. | Trial comparisons |
| Without Complications vs With Complications: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Complications. | Trial comparisons |
| <65 Years vs >=65 Years: Risk Factors for the Proportion of Responders for Hypertension -Age. | Trial comparisons |
| Without Renal Dysfunction vs With Renal Dysfunction: Risk Factors for the Proportion of Responders for Hypercholesterolemia or Familial Hypercholesterolemia -Renal Dysfunction. | Trial comparisons |
| Without Hepatic Dysfunction vs With Hepatic Dysfunction: Risk Factors for the Proportion of Responders for Angina Pectoris -Hepatic Dysfunction. | Trial comparisons |
| Without Hepatic Dysfunction vs With Hepatic Dysfunction: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Hepatic Dysfunction. | Trial comparisons |
| Without Renal Dysfunction vs With Renal Dysfunction: Risk Factors for Incidence Rate of Treatment Related Adverse Events(TRAEs) of Amlodipine/Atorvastatin Combination Tablets -Renal Dysfunction. | Trial comparisons |
| Without Renal Dysfunction vs With Renal Dysfunction: Risk Factors for the Proportion of Responders for Hypertension -Renal Dysfunction. | Trial comparisons |
| Without Concomitant Drugs vs With Concomitant Drugs: Risk Factors for the Proportion of Responders for Hypercholesterolemia or Familial Hypercholesterolemia -Concomitant Drugs. | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01107743/comparisons